Evaluation of the effect of letrozole on symptomatic uterine leiomyomas
Phase 2
- Conditions
- terine Liomyoma.Noninflammatory disorder of uterus, unspecified
- Registration Number
- IRCT201102015444N2
- Lead Sponsor
- Vice chancellor for Research of Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Inclusion criteria : pre menopause patients who have symptomatic liomyomatos equivalent or larger than 3 cm. Exclusion criteria: patients who have received hormonal therapy; patients who have severe medical disorders; patients who have surgical treatment of myoma.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method terine leiomyomas size. Timepoint: before &90 days after 90 days treatment. Method of measurement: sonography.;Uterine size. Timepoint: before &90 days after 90 days treatment. Method of measurement: sonography.
- Secondary Outcome Measures
Name Time Method FSH-LH. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Stradiol. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Ferritine. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.;Patients symptoms. Timepoint: before & after 90 days treatment. Method of measurement: questionnaire.;Hemoglobin. Timepoint: before & after 90 days treatment. Method of measurement: blood sampling.